EP Patent

EP0423805A2 — Condensed purine derivatives

Assigned to KH Neochem Co Ltd · Expires 1991-04-24 · 35y expired

What this patent protects

There are disclosed condensed purine derivatives represented by formula: alkyl or benzyl; each of X¹ and X² independently represents hydrogen, lower alkyl, aralkyl or phenyl; and n is an integer of 0 or 1; R¹ represents hydrogen, lower alkyl, alicyclic alkyl, noradamantan-3…

USPTO Abstract

There are disclosed condensed purine derivatives represented by formula: alkyl or benzyl; each of X¹ and X² independently represents hydrogen, lower alkyl, aralkyl or phenyl; and n is an integer of 0 or 1; R¹ represents hydrogen, lower alkyl, alicyclic alkyl, noradamantan-3-yl, dicyclopropylmethyl or styryl; and R² represents hydrogen, lower alkyl or alicyclic alkyl; or a pharmaceutically acceptable salt thereof. The derivatives and pharmaceutically acceptable salts are useful as diuretics, renal protecting agents, antiallergic agents and hypotensives.

Drugs covered by this patent

Patent Metadata

Patent number
EP0423805A2
Jurisdiction
EP
Classification
Expires
1991-04-24
Drug substance claim
No
Drug product claim
No
Assignee
KH Neochem Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.